Royal Sense Limited
Latest filings
- Promoter releases pledge over 10 lakh Royal Sense shares · Ownership Changes
- Royal Sense Limited - Compliance Certificate under Reg 74(5) SEBI DP Regs for H1 FY27 · Compliance
- Royal Sense appoints internal and secretarial auditors for FY26-27 · Management Changes
Snapshot
What the business is, and whether it's a good one at a fair price.
Develops and sells branded pharmaceutical formulations for the Indian domestic market, with products across antibiotics (Stergiclav 625 and Smartyclav 625), CNS and psychiatric medications (Sterprax and Stergipam MD), pain management (Stergicet with paracetamol and tramadol), sleep aids (Sterpidem MD with zolpidem), and home healthcare devices including a digital blood pressure monitor. Royal Sense Limited sells all pharmaceutical products as prescription-only medicines under Schedule H classification. Through its wholly-owned subsidiary Stergic Retail Private Limited, the company entered pharmacy retail on 23 February 2026 with the first Stergic Pharmacy counter at Deep Vihar, Rohini Sector-22, Delhi. Consolidated FY26 revenue from operations stood at Rs 103.3759 crore, up 67.4% YoY, while standalone revenue grew 36.7% to Rs 3,778.57 lakhs. The subsidiary contributed Rs 416.76 lakhs to consolidated profit after tax of Rs 657.20 lakhs. Employee costs at 3.7% of revenue and other operating expenses at 4.6% are the disclosed cost lines. A new warehouse in Sonipat was taken on a five-year lease from 1 February 2026 to support distribution.
Scorecard
Measured from the filed financials, judged against its Medical Equipment & Supplies peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from Royal Sense Limited's filed financials and exchange disclosures
What does Royal Sense Limited do?
Royal Sense Limited is a Healthcare Equipment & Supplies company listed on BSE.
Is Royal Sense Limited expensive compared with its peers?
On trailing P/E, Royal Sense Limited ranks 1 of 16 in Medical Equipment & Supplies — cheaper than 100% of them, against an industry median of 21.0×. This is a position, not a valuation judgement.
How much does the Royal Sense Limited share price move in a day?
On a typical session Royal Sense Limited moves 2.85% — that is the median absolute close-to-close move across its last 231 trading days. MarketPing measures each filing's price reaction against it.
Where can I track Royal Sense Limited's announcements?
Every NSE and BSE filing by Royal Sense Limited appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.